Products for Research Use Only
RegisterLogin

Linzagolix

CAT: 0013-GTR19174589-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19174589-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Linzagolix is an oral, non-peptide GnRH antagonist in development for uterine fibroids, endometriosis, and adenomyosis. It potently inhibits gonadotropin release, as demonstrated in clinical and preclinical studies, making it a research tool for investigating hormone-dependent gynecological conditions.
CAS Number
935283-04-8
Product Name Alternative
Adenomyosis, Gonadotropin releasing hormone receptor, GNRHR, GnRH Receptor, GNRH Receptor, GNRHReceptor, GnRHR, endometriosis, Inhibitor, OBE 2109, OBE2109, OBE-2109, inhibit, KLH 2109, KLH2109, KLH-2109, Linzagolix, uterine fibroids
Field of Research
Pharmacology & Drug Discovery
Purity
99.33% (May vary between batches)
Solubility
DMSO:55 mg/mL (108.18 mM)
Smiles
COc1cc (F) c (cc1OCc1c (OC) ccc (F) c1F) -n1c (=O) [nH]c2csc (C (O) =O) c2c1=O
Molecular Formula
C22H15F3N2O7S
Molecular Weight
508.42
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
BUP02769-01Linzagolix
HY-120767Linzagolix (choline)
M34100-01Linzagolix choline
RM-L230003-01Linzagolix Impurity 3
RM-L230002-01Linzagolix Impurity 2
RM-L230006-01Linzagolix Impurity 6
RM-L230004-01Linzagolix Impurity 4
RM-L230001-01Linzagolix Impurity 1
RM-L230005-01Linzagolix Impurity 5

Popular Products